TRANSCEPT PHARMACEUTICALS IN's ticker is and the CUSIP is 89354M906. A total of 1 filers reported holding TRANSCEPT PHARMACEUTICALS IN in Q4 2013. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2014 | $18,000 | 0.0% | 9,000 | -1.1% | 0.00% | – |
Q2 2014 | $18,000 | +5.9% | 9,100 | +68.5% | 0.00% | – |
Q1 2014 | $17,000 | -29.2% | 5,400 | -23.9% | 0.00% | – |
Q4 2013 | $24,000 | +14.3% | 7,100 | +6.0% | 0.00% | – |
Q3 2013 | $21,000 | +16.7% | 6,700 | +13.6% | 0.00% | – |
Q2 2013 | $18,000 | – | 5,900 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|